Literature DB >> 8461558

Vitamin D in bone formation.

Y Seino1, S Ishizuka, M Shima, H Tanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8461558     DOI： 10.1007/bf01621905

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  6 in total

1.  The stereochemical configuration of the natural 1 alpha,25-dihydroxyvitamin D3-26,23-lactone.

Authors:  S Ishizuka; J Oshida; H Tsuruta; A W Norman
Journal:  Arch Biochem Biophys       Date:  1985-10       Impact factor: 4.013

2.  The difference of biological activity among four diastereoisomers of 1 alpha,25-dihydroxycholecalciferol-26,23-lactone.

Authors:  S Ishizuka; A W Norman
Journal:  J Steroid Biochem       Date:  1986-10       Impact factor: 4.292

3.  1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells. Study on interaction of IGF-I and 1,25-(OH)2D3.

Authors:  H Kurose; K Yamaoka; S Okada; S Nakajima; Y Seino
Journal:  Endocrinology       Date:  1990-04       Impact factor: 4.736

4.  23(S),25(R)-1,25-dihydroxyvitamin D3-26,23-lactone stimulates murine bone formation in vivo.

Authors:  M Shima; H Tanaka; A W Norman; K Yamaoka; H Yoshikawa; K Takaoka; S Ishizuka; Y Seino
Journal:  Endocrinology       Date:  1990-02       Impact factor: 4.736

5.  The unique action for bone metabolism of 1 alpha,25-(OH)2D3-26,23-lactone.

Authors:  M Kiyoki; N Kurihara; S Ishizuka; S Ishii; Y Hakeda; M Kumegawa; A W Norman
Journal:  Biochem Biophys Res Commun       Date:  1985-03-15       Impact factor: 3.575

6.  1 alpha,25-Dihydroxyvitamin D3[1 alpha,25-(OH)2D3]-26,23-lactone inhibits 1,25-(OH)2D3-mediated fusion of mouse bone marrow mononuclear cells.

Authors:  S Ishizuka; N Kurihara; S Hakeda; N Maeda; K Ikeda; M Kumegawa; A W Norman
Journal:  Endocrinology       Date:  1988-08       Impact factor: 4.736
  6 in total
  2 in total

1.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

Review 2.  [Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy].

Authors:  E Schacht
Journal:  Z Rheumatol       Date:  2000       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.